Tap Into the $65B 'Shroom Boom'

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

INCY
Incyte Corp
NASDAQ
75.59
Open 74.56 Prev Close 74.89
High 75.69 Low 73.81
Volume 1,583,962 Volume (Avg) 1,873
52 Week High 83.95 52 Week Low 53.56
Market Cap 14.8B PE Ratio 17.18

About Incyte Corp

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI (ruxolitinib) for the treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for treating relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a selective fibroblast growth factor receptor kinase inhibitor for the treatment of unresectable biliary tract cancer, metastatic cholangiocarcinoma, and myeloid/lymphoid neoplasms; ICLUSIG (ponatinib), a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma; and NIKTIMVO (axatilimab-csfr) for treating chronic graft-versus-host disease, as well as OPZELURA (ruxolitinib) cream for treating atopic dermatitis. Its clinical stage products include INCB123667 (CDK2) for ovarian cancer; INCB161734 (KRASG12D) for cancers; INCA33890 (TGFßR2xPD-1) for solid tumors; Ruxolitinib cream for mild to moderate hidradenitis suppurativa (HS); Povorcitinib for HS, nonsegmental vitiligo, prurigo nodularis, and asthma and chronic spontaneous urticaria; INCB000262 (MRGPRX2) and INCB000547 (MRGPRX4) for systemic immune and neuro-immune disorders; INCA034460 (anti-CD122) for vitiligo; and Zilurgisertib (ALK2) for fibrodysplasia ossificans progressive. It has collaboration with Genesis Therapeutics, Inc. The company sells its products to specialty and retail pharmacies, hospital pharmacies, and specialty distributors and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.

General

NameIncyte Corp
TickerINCY
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees2,617

Highlights

Analyst Target80.86
Market Cap14,760,900,000
PE Ratio17.18
PEG Ratio0.14
EBITDA1,060,902,016

Share Stats

Shares Outstanding194,120,000
Shares Float192,560,000
Shares Short7,120,000
Insider Holdings199%
Institution Holdings100.74%

Highlights

Analyst Target80.86
Market Cap14,760,900,000
PE Ratio17.18
PEG Ratio0.14
EBITDA1,060,902,016

Valuation

Trailing PE17.87
Forward PE13.14
Price/Sales (Trailing 12 Mt.)3.22
Price/Book (Most Recent Quarter)3.54

Earnings

Most Popular

Jim Cramer Recommends This 'Really, Really Good' Energy Stock

Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.

Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'

President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken and failing its intended purpose.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Trump to visit Federal Reserve headquarters as feud with its chair continues

WASHINGTON (AP) — President Donald Trump is visiting the Federal Reserve headquarters in Washington Thursday, a week after indicating that Fed chair Jerome Powell's on two Fed buildings could be grounds for firing.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Colbert jokes about 'cancel culture' and has a very pointed message for President Donald Trump

Stephen Colbert returned for his first full program after that CBS was canceling his “Late Show” with some supportive late-night guests, a joke about cancel culture and an extremely pointed remark directed at President Donald Trump.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Donald Trump Files $10 Billion Lawsuit Against WSJ And Rupert Murdoch

Donald Trump has filed a $10 billion defamation lawsuit against The Wall Street Journal and Rupert Murdoch.

Allianz Life confirms data breach affecting majority of 1.4M US customers

MINNEAPOLIS (AP) — Hackers gained access to personal data on the majority of the 1.4 million customers of Allianz Life Insurance Company of North America, the company confirmed Saturday.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Coldplay's jumbotron captures — what exactly? The internet has its theories

LONDON (AP) — It started out as a routine bit of fun at a Coldplay concert: Lead singer Chris Martin asked the cameras to scan the crowd for his “Jumbotron Song,” when he sings a few lines about the people the camera lands on.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

Tea-loving Nepal is warming up to coffee

KATHMANDU, Nepal (AP) — Coffee hasn't always been an easy sell in .

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008

A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.

Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad

The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.

AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?

Risk appetite took a breather Tuesday, with major U.S. stock indices retreating modestly from record highs as investors braced for a pivotal stretch of earnings and macro events.

Pakistan urges global social media platforms to block accounts run by banned militant groups

ISLAMABAD (AP) — on Friday urged to take action to block hundreds of accounts allegedly run by outlawed militant groups that Islamabad claims spread propaganda and glorify insurgents in the South Asian country.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

FOMC Meeting Preview: Will Jerome Powell Accelerate The Bitcoin, Ethereum, XRP Bull Run?

Bitcoin (CRYPTO: BTC) and other cryptocurrencies continue to trade sideways ahead of Wednesday’s Federal Open Market Committee meeting, though pundits expect volatility to pick up soon.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Celestica Stock Surges On Q2 Earnings Beat, Company Raises 2025 Outlook On 'Strengthening' Demand

Celestica announces financial results for the second quarter Monday after the bell. Here's a rundown of the supply chain solutions company's report.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Trump's tariffs could squeeze US factories and boost costs by up to 4.5%, a new analysis finds

WASHINGTON (AP) — As President prepares to announce new tariff increases, the costs of his policies are starting to come into focus for a domestic manufacturing sector that depends on global supply chains, with a new analysis suggesting factory costs could increase by roughly 2% to 4.5%.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Cathie Wood's $15M Crypto Bet: Sells Bitcoin King Block, Doubles Down On Ethereum Giant Bitmine Immersion

On Tuesday, Cathie Wood-led Ark Invest executed significant trades, focusing on Bitmine Immersion Technologies Inc. (NYSE:BMNR) and Block Inc. (NYSE:XYZ).

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service